Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Allison R Moreau"'
Autor:
Timothy A. Yap, Cynthia Basu, Jonathan W. Goldman, Michael Gordon, Erika Hamilton, Adrianne Kelly, Feng Liu, Allison R. Moreau, Heather Neumann, Kyriakos Papadopoulos, Hope S. Rugo, Geoffrey I. Shapiro, Shaveta Vinayak, Li Zhou, Komal Jhaveri
Publikováno v:
Cancer Research. 82:P5-16
Introduction: Despite initial efficacy, most patients (pts) with HR+/HER2– advanced breast cancer (BC) eventually progress on endocrine therapy (ET) plus a CDK4/6 inhibitor (CDK4/6i). In preclinical models, resistance to ET + CDK4/6i can be overcom
Autor:
Dawei Xuan, Valentina Boni, Xiaohua Xin, Shilpa Alekar, Anthony W. Tolcher, Jasgit C. Sachdev, Nehal Lakhani, Victor Moreno, Ruifeng Li, Amy Jackson-Fisher, Erica Stringer-Reasor, Michael L. Maitland, Allison R Moreau, Shivaani Kummar, Michelle Bowers, Emiliano Calvo, Eric L. Powell, Manish R. Sharma
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(16)
Purpose: We investigated safety, tolerability, pharmacokinetics, and antitumor activity of the protein tyrosine kinase 7 (PTK7)-targeted, auristatin-based antibody–drug conjugate (ADC) PF-06647020/cofetuzumab pelidotin (NCT02222922). Patients and M
Autor:
Matt S, Anderson, William D, Hanley, Allison R, Moreau, Bo, Jin, Frederick A, Bieberdorf, James T, Kost, Larissa A, Wenning, Julie A, Stone, John A, Wagner, Marian, Iwamoto
Publikováno v:
British journal of clinical pharmacology. 71(4)
Oral contraceptives such as norgestimate-ethinyl estradiol (Ortho Tri-Cyclen®) are commonly prescribed in the HIV-infected patient population. A placebo-controlled, randomized, two-period crossover study in healthy HIV-seronegative subjects was cond